AI assistant
CLEARVUE TECHNOLOGIES LIMITED — Capital/Financing Update 2023
Dec 13, 2023
64697_rns_2023-12-13_a00075bf-3c9f-466d-b6a2-48c9d1126b7f.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ASX Announcement
14 December 2023
==> picture [179 x 62] intentionally omitted <==
==> picture [51 x 51] intentionally omitted <==
ASX RELEASE ǀ CLEARVUE TECHNOLOGIES LIMITED (ASX:CPV | OTC:CVUEF)
Issue of Securities and Cleansing Notice
On 13 December 2023, ClearVue Technologies Limited (ASX:CPV) ( ClearVue or the Company ) issued various securities as set out below:
-
A total of 400,000 fully paid ordinary shares (Shares) upon exercise of 400,000 unlisted options (Options) at $0.25 per Option. As a result of the exercise of the Options, the Company received $100,000. The Shares were issued under exception 9 of ASX Listing Rule 7.1 and therefore have not utilized the Company’s placement capacity available under Listing Rule 7.1 or 7.1A. An Appendix 2A detailing the issue of these Shares will follow this announcement.
-
A total of 250,000 Shares upon exercise of 250,000 Options at $0.30 per Option. As a result of the exercise of the Options, the Company received $75,000. The Shares were issued under exception 9 of ASX Listing Rule 7.1 and therefore have not utilized the Company’s placement capacity available under Listing Rule 7.1 or 7.1A. An Appendix 2A detailing the issue of these Shares will follow this announcement.
-
A total of 90,249 Shares to the Company’s European markets consultant and a total of 127,637 Shares to the Company’s ESG adviser. The issue of these Shares utilized the Company’s existing placement capacity available under Listing Rule 7.1. An Appendix 2A detailing the issue of these Shares will follow this announcement.
-
A total of 2,000,000 unlisted options to directors (Director Options) with an exercise price of $0.50 per Director Option expiring on 13 December 2026. The issue of these Director Options was approved by shareholders at the Company’s AGM held on 30 November 2023 and do not utilize the Company’s placement capacity available under Listing Rule 7.1 or 7.1A. An Appendix 3G detailing the issue of these Director Options will follow this announcement.
-
A total of 2,000,000 Director Options with an exercise price of $1.00 per Director Option expiring on 13 December 2026. The issue of these Director Options was approved by shareholders at the Company’s AGM held on 30 November 2023 and do not utilize the Company’s placement capacity available under Listing Rule 7.1 or 7.1A. An Appendix 3G detailing the issue of these Director Options will follow this announcement.
Cleansing Notice
For the purposes of section 708A(6) of the Corporations Act, the Company gives notice under section 708A(5)(e) of the Corporations Act as follows:
-
a) the Company issued the Shares without disclosure to investors under Part 6D.2 of the Corporations Act;
-
b) as at the date of this notice the Company has complied with:
1
Suite 7 / 567 Newcastle Street, West Perth, Western Australia 6005 P: +61 8 9220 9020 F: +61 8 9220 9029 E: [email protected] W: www.clearvuepv.com
-
i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and ii) section 674 of the Corporations Act; and
-
c) as at the date of this notice, there is no excluded information of the type referred to in sections 708A(7) and 708A(8) of the Corporations Act.
Authorised by the Company Secretary of ClearVue Technologies Limited.
Contact:
Harry Miller, Company Secretary Email: [email protected]
==> picture [87 x 30] intentionally omitted <==
2
AXS Announcement | 14 December 2023